Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8737195 | Diagnostic Microbiology and Infectious Disease | 2018 | 10 Pages |
Abstract
We tested the in vitro activity of oritavancin against 60 vancomycin-susceptible enterococci (VSE) and 27 vancomycin-resistant enterococci (VRE). The oritavancin MIC ranged from â¤0.002 to 0.5 μg/mL; the minimum biofilm bactericidal concentration ranged from â¤0.002 to 2 μg/mL. Oritavancin has promising in vitro activity against VSE and VRE in both planktonic and biofilm states.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Qun Yan, Melissa J. Karau, Robin Patel,